Krebs Biochemicals and Industries Limited (KREBSBIO.NS) share price
Krebs Biochemicals and Industries Limited (NSE:KREBSBIO.NS) last traded at INR 57.5, down 0.62% on the day (quote 2026-11-08 09:43 UTC), with a market cap of INR 124.0 Cr and a 52-week range of INR 38.33 to INR 76.85.
| Exchange | NSE |
|---|---|
| Currency | INR |
| Last price | INR 57.5 |
| 1-day move | -0.62% |
| 52-week range | INR 38.33 - INR 76.85 |
| Market cap | INR 124.0 Cr |
| From 52-week high | -25.20% |
| Volume vs average | 0.3x |
| Falling Shares risk score | 9/100 (LOW) |
| Country | India |
| ISIN | INE268B01013 |
Frequently asked questions
Why is Krebs Biochemicals and Industries Limited falling today?
Krebs Biochemicals and Industries Limited (NSE:KREBSBIO.NS) is down 0.62% at its latest quote and trades 25.2% below its 52-week high. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.
What is the Krebs Biochemicals and Industries Limited share price today?
Krebs Biochemicals and Industries Limited (NSE:KREBSBIO.NS) last traded at INR 57.5, a -0.62% move on the day as of 2026-11-08 09:43 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.
What is the 52-week range of Krebs Biochemicals and Industries Limited?
Krebs Biochemicals and Industries Limited's 52-week low is INR 38.33 and its 52-week high is INR 76.85; the shares trade 25.2% below the high.
What is the market cap of Krebs Biochemicals and Industries Limited?
Krebs Biochemicals and Industries Limited has a market capitalisation of about INR 124.0 Cr at the latest price.
What are the risks of investing in Krebs Biochemicals and Industries Limited?
Falling Shares Intelligence rates Krebs Biochemicals and Industries Limited 9/100 (LOW) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.
Data is compiled from public exchange feeds and may be delayed. Not investment advice.
Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com